Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion

Molecular Brain Research

Volumn 92, Issue 1-2, 2001, Pages 66-77

  Basura, Gregory J ^a   Walker, Paul D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 Hydroxydopamine; Basal ganglia; In situ hybridization; Preproenkephalin; Preprotachykinin; Substance P

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; DOPAMINE; ENKEPHALIN; KETANSERIN; MESSENGER RNA; OXIDOPAMINE; PREPROENKEPHALIN; PREPROTACHYKININ; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 2A AGONIST; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CATECHOLAMINE DEPLETION; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; INHIBITION KINETICS; NEWBORN; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SEROTONIN RELEASE;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINES; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; ENKEPHALINS; GENE EXPRESSION REGULATION; HYDROXYINDOLEACETIC ACID; IN SITU HYBRIDIZATION; KETANSERIN; MALE; NEURONS; OXIDOPAMINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYMPATHOLYTICS; TACHYKININS; TRANSCRIPTION, GENETIC;

ANIMALIA; RODENTIA;

EID: 0035882231     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00151-6     Document Type: Article

References (50)

1. 125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region
2. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system
3. Neurokinin-3 receptors modulate dopamine cell function and alter the events of 6-hydroxydopamine
4. Differential sensitivity of tachykinin vs. enkephalin gene expression in the posterior striatum in response to acute p-chloroamphetamine treatment during postnatal development
5. Serotonin 2A receptor mRNA levels in the neonatal dopamine depleted rat striatum remain upregulated following suppression of serotonin hyperinnervation
6. Suppression of serotonin hyperinnervation does not alter the dysregulatory influences of dopamine depletion on striatal neuropeptide gene expression in rodent neonates
7. Serotonin 2A and 2C receptor biosynthesis in the rodent striatum during postnatal development: mRNA expression and functional linkage to neuropeptide gene regulation
8. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression
9. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization
10. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats
11. MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression
12. Selective 5-HT2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex
13. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover
14. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra
15. Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin
16. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats
17. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease
18. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in rat striatum
19. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine
20. Striatonigral dynorphin and substance P pathways in the rat. II. Functional analysis
21. In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy
22. [3H]MDL 100,907: A novel selective 5-HT2A receptor ligand
23. Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain
24. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats
25. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A
26. 2A receptor and its mRNA in a subpopulation of rat striatal neurons
27. 2 receptor binding sites: Binding properties, brain distribution and functional role
28. Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long lasting serotonin-S2 antagonist
29. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation
30. Protein measurement with the Folin phenol reagent
31. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment
32. 125I]DOI, a new psychomimetic radioligand
33. Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the rat striatum and globus pallidus: Studies with fluoxetine and DOI
34. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis
35. 2 receptor mRNA in rat striatum following 6-OHDA lesions of the adult nigrostriatal pathway
36. 2C receptors
37. Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study
38. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: Implications for human Parkinson's disease
39. Putative selective 5-HT2 antagonists block serotonin 5-HT1C receptors in the choroid plexus
40. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression
41. Serotonergic regulation of striatal dynorphin and substance P systems: A study with serotonin uptake inhibitor fluoxetine
42. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats
43. Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions
44. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum
45. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions
46. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission
47. 6 with neuropeptides in rat striatum
48. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: Evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis
49. Rat brain preproenkephalin mRNA